Wermuth C - Search Results

1

Emotion work in interpreter-mediated consultations: A systematic literature review.

Theys L, Krystallidou D, Salaets H, Wermuth C, Pype P. Theys L, et al. Among authors: wermuth c. Patient Educ Couns. 2020 Jan;103(1):33-43. doi: 10.1016/j.pec.2019.08.006. Epub 2019 Aug 12. Patient Educ Couns. 2020. PMID: 31431309 Review.

2

Doctors, Patients, and Interpreters' Views on the Co-Construction of Empathic Communication in Interpreter-Mediated Consultations: A Qualitative Content Analysis of Video Stimulated Recall Interviews.

Theys L, Wermuth C, Hsieh E, Krystallidou D, Pype P, Salaets H. Theys L, et al. Among authors: wermuth c. Qual Health Res. 2022 Oct;32(12):1843-1857. doi: 10.1177/10497323221119369. Epub 2022 Aug 26. Qual Health Res. 2022. PMID: 36017592

3

Use of a fluorescent polarization based high throughput assay to identify new calmodulin ligands.

Dagher R, Pigault C, Bonnet D, Boeglin D, Pourbaix C, Kilhoffer MC, Villa P, Wermuth CG, Hibert M, Haiech J. Dagher R, et al. Among authors: wermuth cg. Biochim Biophys Acta. 2006 Nov;1763(11):1250-5. doi: 10.1016/j.bbamcr.2006.09.027. Epub 2006 Sep 26. Biochim Biophys Acta. 2006. PMID: 17081635 Free article.

4

Similarity in drugs: reflections on analogue design.

Wermuth CG. Wermuth CG. Drug Discov Today. 2006 Apr;11(7-8):348-54. doi: 10.1016/j.drudis.2006.02.006. Drug Discov Today. 2006. PMID: 16580977 Review.

5

Selective optimization of side activities: the SOSA approach.

Wermuth CG. Wermuth CG. Drug Discov Today. 2006 Feb;11(3-4):160-4. doi: 10.1016/S1359-6446(05)03686-X. Drug Discov Today. 2006. PMID: 16533714 Review.

6

Multitargeted drugs: the end of the "one-target-one-disease" philosophy?

Wermuth CG. Wermuth CG. Drug Discov Today. 2004 Oct 1;9(19):826-7. doi: 10.1016/S1359-6446(04)03213-1. Drug Discov Today. 2004. PMID: 15381132 No abstract available.

7

Development of novel 1,2,3,4-tetrahydroisoquinoline derivatives and closely related compounds as potent and selective dopamine D3 receptor ligands.

Mach UR, Hackling AE, Perachon S, Ferry S, Wermuth CG, Schwartz JC, Sokoloff P, Stark H. Mach UR, et al. Among authors: wermuth cg. Chembiochem. 2004 Apr 2;5(4):508-18. doi: 10.1002/cbic.200300784. Chembiochem. 2004. PMID: 15185375

8

Prednisone reduces muscle degeneration in dystrophin-deficient Caenorhabditis elegans.

Gaud A, Simon JM, Witzel T, Carre-Pierrat M, Wermuth CG, Ségalat L. Gaud A, et al. Among authors: wermuth cg. Neuromuscul Disord. 2004 Jun;14(6):365-70. doi: 10.1016/j.nmd.2004.02.011. Neuromuscul Disord. 2004. PMID: 15145337

9

Selective optimization of side activities: another way for drug discovery.

Wermuth CG. Wermuth CG. J Med Chem. 2004 Mar 11;47(6):1303-14. doi: 10.1021/jm030480f. J Med Chem. 2004. PMID: 14998318 Review. No abstract available.

10

N-(omega-(4-(2-methoxyphenyl)piperazin-1-yl)alkyl)carboxamides as dopamine D2 and D3 receptor ligands.

Hackling A, Ghosh R, Perachon S, Mann A, Höltje HD, Wermuth CG, Schwartz JC, Sippl W, Sokoloff P, Stark H. Hackling A, et al. Among authors: wermuth cg. J Med Chem. 2003 Aug 28;46(18):3883-99. doi: 10.1021/jm030836n. J Med Chem. 2003. PMID: 12930150

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

87 results

Search Page

Filters